BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17934094)

  • 1. Joint remodelling in inflammatory disease.
    Schett G
    Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii42-4. PubMed ID: 17934094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti cytokine therapy in chronic inflammatory arthritis.
    Thompson C; Davies R; Choy E
    Cytokine; 2016 Oct; 86():92-99. PubMed ID: 27497159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis.
    Lories RJ; Baeten DL
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S10-4. PubMed ID: 19822039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid involvement in chronic inflammatory rheumatological disorders.
    Bianchi G; Marchesini G; Zoli M; Falasconi MC; Iervese T; Vecchi F; Magalotti D; Ferri S
    Clin Rheumatol; 1993 Dec; 12(4):479-84. PubMed ID: 8124909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seronegative arthritis].
    van Rijswijk MH
    Ned Tijdschr Geneeskd; 1989 Jul; 133(27):1356-9. PubMed ID: 2677756
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone remodeling in rheumatic disease: a question of balance.
    Walsh NC; Gravallese EM
    Immunol Rev; 2010 Jan; 233(1):301-12. PubMed ID: 20193007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cardiovascular disease on chronic inflammatory joint disease: reverse causality?
    Castañeda S; Vicente-Rabaneda EF; Valero C; Remuzgo-Martínez S; López-Mejías R; González-Gay MA
    Expert Rev Clin Immunol; 2020 Sep; 16(9):855-858. PubMed ID: 32867563
    [No Abstract]   [Full Text] [Related]  

  • 8. Basic synovial biology and immunopathology in psoriatic arthritis.
    Robinson H; Kelly S; Pitzalis C
    J Rheumatol Suppl; 2009 Aug; 83():14-6. PubMed ID: 19661529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Microparticles in the Pathogenesis of Inflammatory Joint Diseases.
    Krajewska-Włodarczyk M; Owczarczyk-Saczonek A; Żuber Z; Wojtkiewicz M; Wojtkiewicz J
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoimmunology.
    Okamoto K; Takayanagi H
    Cold Spring Harb Perspect Med; 2019 Jan; 9(1):. PubMed ID: 29610150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of IL-17 in the Human Immune System and Its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis.
    Jaller Char JJ; Jaller JA; Waibel JS; Bhanusali DG; Bhanusali N
    J Drugs Dermatol; 2018 May; 17(5):539-542. PubMed ID: 29742185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal bone involvement in inflammatory arthritis: the role of IL17.
    Rossini M; Viapiana O; Adami S; Idolazzi L; Fracassi E; Gatti D
    Rheumatol Int; 2016 Apr; 36(4):469-82. PubMed ID: 26521079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential mechanisms of de-regulated bone formation in rheumatoid arthritis and spondyloarthritis.
    Goldring SR
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii56-ii60. PubMed ID: 27856661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
    Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
    J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune joint diseases in Late Medieval skeletal sample from Croatia.
    Rajić Sikanjić P; Vlak D
    Rheumatol Int; 2010 Jan; 30(3):349-56. PubMed ID: 19455335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of tumour necrosis factor α blockade on bone metabolism in chronic inflammatory joint diseases].
    Aguilar Del Rey FJ; García Portales R; Haro Liger M; Rodríguez Andreu J; Casals Sánchez JL; Pérez González R
    Med Clin (Barc); 2016 Jul; 147(2):56-62. PubMed ID: 27209224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
    Voulgari PV
    Expert Rev Clin Immunol; 2010 Sep; 6(5):721-33. PubMed ID: 20828280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: Immune cells and mediators of inflammatory arthritis.
    Schett G
    Autoimmunity; 2008 Apr; 41(3):224-9. PubMed ID: 18365836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: a literature review.
    Coiffier G; Bouvard B; Chopin F; Biver E; Funck-Brentano T; Garnero P; Guggenbuhl P
    Joint Bone Spine; 2013 May; 80(3):250-7. PubMed ID: 23142254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balance of tissue repair and remodeling in chronic arthritis.
    Lories R
    Nat Rev Rheumatol; 2011 Oct; 7(12):700-7. PubMed ID: 22009331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.